The conclusion that routine CSF abnormalities largely do not seem to reflect mechanisms specific to PCS is argued against routine CSF diagnostics as a source of disease-specific biomarkers in unselected PCS patients and support future studies focusing on alternative mechanisms underlying persistent neurological symptoms.
Abstract
Persistent neurological symptoms are among the most disabling manifestations of post-COVID-19 syndrome (PCS), yet the contribution of ongoing CNS immune activation remains uncertain. CSF studies including clinically relevant COVID-19 recovered control cohorts are scarce. In this prospective single-center study, we enrolled 50 patients fulfilling the WHO criteria for PCS (COVIDpost, mean age +/- standard deviation [SD] 43.41 +/- 11.99 years, 30 % male, 70 % female) and 50 individuals who had fully recovered from COVID-19 (COVIDreco, mean age +/- SD 39.38 +/- 13.45, 42 % male, 58 % female). Both cohorts were comparable regarding age (p = 0.07), sex (p = 0.30), and education (p = 0.84). All participants underwent paired CSF and serum analyses together with comprehensive neuropsychological assessment. Routine CSF parameters, blood-CSF barrier integrity, oligoclonal bands (OCB), SARS-CoV-2 RNA in CSF and blood, pathogen-specific antibody indices, and neuronal autoantibodies were investigated. Despite marked differences in cognitive performance (p < 0.001) and fatigue severity (p < 0.001), patients with PCS showed no evidence of disease-specific CSF abnormalities compared to recovered controls. Routine CSF parameters, blood-CSF barrier dysfunction, CSF-restricted OCB, SARS-CoV-2 RNA in CSF and blood, intrathecal SARS-CoV-2 antibody synthesis, polyspecific antiviral immune responses, and neuronal autoantibodies were comparable between groups. SARS-CoV-2-specific IgG concentrations in CSF correlated positively with serum concentrations (COVIDpost: r [95%CI] = 0.78 [0.62 - 0.87]; COVIDreco: r [95%CI] = 0.86 [0.75 - 0.92]; both p < 0.001) and albumin quotient (COVIDpost: r [95%CI] = 0.52 [0.26 - 0.71], p < 0.001; COVIDreco: r [95%CI] = 0.37 [0.10 - 0.60]; p = 0.01), consistent with passive transfer across the blood-CSF barrier rather than compartmentalized intrathecal immune activation. Furthermore, SARS-CoV-2-specific antibody measures were not associated with cognitive performance (p > 0.72) or fatigue severity (p > 0.88). This study provides no evidence that persistent neurological symptoms after COVID-19 are accompanied by ongoing adaptive CNS immune activation, disease-specific neuronal autoimmunity, or intrathecal SARS-CoV-2-specific humoral immune responses. The inclusion of a carefully phenotyped COVID-19 recovered comparison cohort strengthens the conclusion that routine CSF abnormalities largely do not seem to reflect mechanisms specific to PCS. These findings argue against routine CSF diagnostics as a source of disease-specific biomarkers in unselected PCS patients and support future studies focusing on alternative mechanisms underlying persistent neurological symptoms.
Post-COVID syndrome (PCS) involves multisystemic effects, occurring even after a relatively mild acute illness. “To determine the frequency and nature of ongoing symptoms in Upper Egypt at 3 and 6 months post-acute COVID-19, characterize patient groups at risk for PCS, and evaluate changes in clinical parameters. This...
Mohamed K.Darwish, M. El-kholy, Amine Azzouz et al.· Egyptian Journal of Bronchol...· 0 citations
PAS and PACVS exhibit substantial clinical and immunological overlap, including GPCR-directed autoreactivity and altered receptor-reactive T-cell responses, which suggest overlapping pathophysiological mechanisms.
J. Dinser, M. Anft, L. Wiemers et al.· medRxiv· 0 citations
This narrative review provides a critical synthesis of current literature regarding the clinical presentations, potential mechanisms, and biomarkers associated with neurological involvement in Long COVID and helps define disease heterogeneity, support patient stratification, and guide future personalized therapeutic ap...
M. Bralic, F. Silconi, Vladimira Vuletić et al.· Journal of Clinical Medicine· 0 citations
ABSTRACT Pathophysiological mechanisms of neurological manifestations in COVID‐19 are not fully known yet. In this case‐control study, proteomic analysis was used to characterize cerebrospinal fluid (CSF) samples from COVID‐19 patients with acute neurological manifestations primarily categorized as: isolated refractory...
Nicole Lardini Freitas, Y. Gomes, F. C. Nogueira et al.· Journal of Medical Virology· 0 citations
Long COVID (LC) is characterized by persistent symptoms following acute SARS-CoV-2 infection. Common symptoms include post-exertional malaise (PEM), fatigue, cognitive impairments, and orthostatic intolerance. The underlying pathophysiological mechanism of LC remains poorly understood and studies involving patients a...
Bart Humer, J. Berentschot, C. V. van Helden-Meeuwsen et al.· Scientific Reports· 1 citation
The neurological and neuropsychiatric manifestations of long COVID remain incompletely understood. Reactivation of latent herpesviruses has been proposed as a contributing mechanism, but human herpesvirus 7 (HHV-7) has received limited attention despite its neurotropic potential. We conducted a retrospective analysis o...
Diane Ducret, Tatjana Mijatovic· Viruses· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.